Nanomedicines Market, By Modality, By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

List of Tables

REPORT HIGHLIGHT

Nanomedicines Market size was valued at USD 231.04 Million in 2023, expanding at a CAGR of 12.92% from 2024 to 2032.

The nanomedicine market encompasses the use of nanotechnology for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications. The development of personalized nanomedicines tailored to individual patient profiles, and increasing research focus on combination therapies and multifunctional nanoplatforms. However, restraints in the nanomedicine market include challenges related to regulatory approvals and safety concerns associated with nanomaterials. Opportunities abound in the integration of nanotechnology with other emerging technologies like artificial intelligence and gene editing for precision medicine approaches.

Nanomedicines Market- Market Dynamics

Rapidly increasing utilization of nanotechnology in drug delivery methods to propel market demand

The adoption of nanotechnology-based methods for drug delivery is experiencing rapid growth, driven by the advantages offered in terms of targeted delivery, enhanced drug efficacy, and reduced side effects. This growth is fueled by increasing investments in research and development, advancements in nanomaterials and drug delivery technologies, and a rising demand for personalized and precision medicine solutions. Additionally, the COVID-19 pandemic has further accelerated the adoption of nanotechnology in drug delivery, with the development of nanomedicine-based vaccines and therapeutics to combat the virus.

Nanomedicines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.92% over the forecast period (2024-2032)

Based on Modality segmentation, Treatment was predicted to show maximum market share in the year 2023

Based on application segmentation, Drug Delivery was the leading type in 2023

Based on Indication segmentation, Cardiovascular

was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Nanomedicines Market- Segmentation Analysis:

The Global Nanomedicines Market is segmented on the basis of Modality, Application, Indication, Molecule Type, and Region.

The market is divided into two categories based on Modality: Treatment involves the use of nanomedicines for therapeutic purposes, targeting specific diseases or medical conditions. Diagnostics utilizes nanotechnology for diagnosing diseases or conditions, often through advanced imaging or detection methods.

The market is divided into two categories based on application: Drug Delivery focuses on the use of nanomedicines for targeted drug delivery, enhancing drug efficacy, and minimizing side effects. IVD utilizes nanotechnology for diagnostic tests performed outside the body, such as blood tests or genetic testing. An implant involves the use of nanomaterials in medical implants, such as orthopedic implants or dental implants, to improve biocompatibility and performance.

Nanomedicines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced research infrastructure, robust regulatory frameworks, and significant investments in nanomedicine research and development. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Nanomedicines Market- Competitive Landscape:

Several key players are dominaning the market through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies like Abbott Laboratories, Johnson & Johnson, and Pfizer lead the market with diverse portfolios of nanomedicine products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Gilead Sciences, and Novartis contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In January 2022, Pfizer Inc. and Acuitas Therapeutics disclosed a development and option agreement, wherein Pfizer will hold the opportunity to license Acuitas' LNP technology for potential utilization in up to ten targets for vaccine or therapeutic development on a non-exclusive basis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi SA

Celgene Corporation

Nanobiotix

Luminex Corporation

Nanospectra Biosciences Inc

NanoCarrier Co. Ltd

Johnson & Johnson Services Inc

Merck & Co., Inc

Pfizer, Inc.

NanoCarrier Co. Ltd

Taiwan Liposome Company Ltd

Hoffmann-La Roche AG (Roche)

Gilead Science Inc

Ipsen SA.

Others

GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

Treatment
Diagnostics

GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Drug Delivery
IVD
Implant
Vaccine
Others

GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Oncology
Infectious
Cardiovascular
Neurological

GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032

Nanoparticle
Nanotube
Nanodevice

GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV2665

1.Nanomedicines Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Nanomedicines Market Snippet by Modality
- 2.1.2.Nanomedicines Market Snippet by Application
- 2.1.3.Nanomedicines Market Snippet by Indication
- 2.1.4.Nanomedicines Market Snippet by Molecule Type
- 2.1.5.Nanomedicines Market Snippet by Country
- 2.1.6.Nanomedicines Market Snippet by Region
2.2.Competitive Insights

3.Nanomedicines Key Market Trends

3.1.Nanomedicines Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Nanomedicines Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Nanomedicines Market Opportunities
3.4.Nanomedicines Market Future Trends

4.Nanomedicines Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Nanomedicines Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Nanomedicines Market Landscape

6.1.Nanomedicines Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Nanomedicines Market - By Modality

7.1.Overview
- 7.1.1.Segment Share Analysis, By Modality, 2023 & 2032 (%)
- 7.1.2.Treatment
- 7.1.3.Diagnostics

8.Nanomedicines Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Drug Delivery
- 8.1.3.IVD
- 8.1.4.Implant
- 8.1.5.Vaccine
- 8.1.6.Others

9.Nanomedicines Market - By Indication

9.1.Overview
- 9.1.1.Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 9.1.2.Oncology
- 9.1.3.Infectious
- 9.1.4.Cardiovascular
- 9.1.5.Neurological

10.Nanomedicines Market - By Molecule Type

10.1.Overview
- 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 10.1.2.Nanoparticle
- 10.1.3.Nanotube
- 10.1.4.Nanodevice

11.Nanomedicines Market- By Geography

11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2.North America
- 11.2.1.Overview
- 11.2.2.Nanomedicines Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
  - 11.2.8.1.Overview
  - 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3.U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.8.5.U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.2.8.6.U.S. Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
  - 11.2.9.1.Overview
  - 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3.Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.2.9.5.Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.2.9.6.Canada Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.3.Europe
- 11.3.1.Overview
- 11.3.2.Nanomedicines Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
  - 11.3.8.1.Overview
  - 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3.Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.8.5.Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.8.6.Germany Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
  - 11.3.9.1.Overview
  - 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3.Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.9.5.Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.9.6.Italy Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
  - 11.3.10.1.Overview
  - 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3.United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.10.5.United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.10.6.United Kingdom Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.11.France
  - 11.3.11.1.Overview
  - 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3.France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.11.5.France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.11.6.France Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
  - 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2.Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.12.4.Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.12.5.Russia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
  - 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2.Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.13.4.Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.13.5.Netherlands Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
  - 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2.Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.14.4.Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.14.5.Sweden Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
  - 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2.Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.15.4.Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.15.5.Poland Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
  - 11.3.16.1.Overview
  - 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3.Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.3.16.5.Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.16.6.Rest of the Europe Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Nanomedicines Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.8.India
  - 11.4.8.1.Overview
  - 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3.India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.8.5.India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.8.6.India Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.9.China
  - 11.4.9.1.Overview
  - 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3.China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.9.5.China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.9.6.China Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
  - 11.4.10.1.Overview
  - 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3.Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.10.5.Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.10.6.Japan Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
  - 11.4.11.1.Overview
  - 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3.South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.11.5.South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.11.6.South Korea Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
  - 11.4.12.1.Overview
  - 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3.Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.12.5.Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.12.6.Australia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
  - 11.4.13.1.Overview
  - 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3.Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.13.5.Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.13.6.Thailand Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
  - 11.4.14.1.Overview
  - 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3.Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.14.5.Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.14.6.Indonesia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
  - 11.4.15.1.Overview
  - 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3.Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.15.5.Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.15.6.Philippines Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
  - 11.4.16.1.Overview
  - 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3.Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.4.16.5.Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.16.6.Rest of APAC Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Nanomedicines Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
  - 11.5.8.1.Overview
  - 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3.Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.8.5.Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.8.6.Brazil Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
  - 11.5.9.1.Overview
  - 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3.Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.9.5.Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.9.6.Mexico Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
  - 11.5.10.1.Overview
  - 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3.Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.10.5.Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.10.6.Argentina Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
  - 11.5.11.1.Overview
  - 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3.Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.11.5.Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.11.6.Colombia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
  - 11.5.12.1.Overview
  - 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3.Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.5.12.5.Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.12.6.Rest of LATAM Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Nanomedicines Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
  - 11.6.8.1.Overview
  - 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3.Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.8.5.Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.8.6.Saudi Arabia Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
  - 11.6.9.1.Overview
  - 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3.United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.9.5.United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.9.6.United Arab Emirates Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
  - 11.6.10.1.Overview
  - 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3.Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.10.5.Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.10.6.Israel Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
  - 11.6.11.1.Overview
  - 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3.Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.11.5.Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.11.6.Turkey Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
  - 11.6.12.1.Overview
  - 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3.Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.12.5.Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.12.6.Algeria Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
  - 11.6.13.1.Overview
  - 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3.Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.13.5.Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.13.6.Egypt Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
  - 11.6.14.1.Overview
  - 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3.Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
  - 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 11.6.14.5.Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.14.6.Rest of MEA Market Size and Forecast, By Molecule Type, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Nanomedicines Industry

12.1.Competitive Dashboard
12.2.Company Profiles
- 12.2.1.Sanofi SA
- 12.2.2.Celgene Corporation
- 12.2.3.Nanobiotix
- 12.2.4.Luminex Corporation
- 12.2.5.Nanospectra Biosciences Inc
- 12.2.6.NanoCarrier Co. Ltd
- 12.2.7.Johnson & Johnson Services Inc
- 12.2.8.Merck & Co., Inc
- 12.2.9.Pfizer, Inc.
- 12.2.10.NanoCarrier Co. Ltd
- 12.2.11.Taiwan Liposome Company Ltd
- 12.2.12.Hoffmann-La Roche AG (Roche)
- 12.2.13.Gilead Science Inc
- 12.2.14.Ipsen SA.
- 12.2.15.Others

13.360 Degree Analyst View

14.Appendix

14.1.Research Methodology
14.2.References
14.3.Abbreviations
14.4.Disclaimer
14.5.Contact Us

Product Code: ANV2665

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Nanomedicines Market: Modality Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Modality
TABLE Global Nanomedicines Market, by Modality 2019-2032 (USD Million)
TABLE Nanomedicines Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Nanomedicines Market, by Application 2019-2032 (USD Million)
TABLE Nanomedicines Market: Indication Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Indication
TABLE Global Nanomedicines Market, by Indication 2019-2032 (USD Million)
TABLE Nanomedicines Market: Molecule Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Molecule Type
TABLE Global Nanomedicines Market, by Molecule Type 2019-2032 (USD Million)
TABLE Nanomedicines Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Nanomedicines Market, by Region 2019-2032 (USD Million)
TABLE North America Nanomedicines Market, by Country, 2019-2032 (USD Million)
TABLE North America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
TABLE North America Nanomedicines Market, by Application, 2019-2032 (USD Million)
TABLE North America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
TABLE North America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
TABLE Europe Nanomedicines Market, by Country, 2019-2032 (USD Million)
TABLE Europe Nanomedicines Market, by Modality, 2019-2032 (USD Million)
TABLE Europe Nanomedicines Market, by Application, 2019-2032 (USD Million)
TABLE Europe Nanomedicines Market, by Indication, 2019-2032 (USD Million)
TABLE Europe Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
TABLE Asia Pacific Nanomedicines Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Nanomedicines Market, by Modality, 2019-2032 (USD Million)
TABLE Asia Pacific Nanomedicines Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Nanomedicines Market, by Indication, 2019-2032 (USD Million)
TABLE Asia Pacific Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
TABLE Latin America Nanomedicines Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Nanomedicines Market, by Modality, 2019-2032 (USD Million)
TABLE Latin America Nanomedicines Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Nanomedicines Market, by Indication, 2019-2032 (USD Million)
TABLE Latin America Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Nanomedicines Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Nanomedicines Market, by Modality, 2019-2032 (USD Million)
TABLE Middle East and Africa Nanomedicines Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Nanomedicines Market, by Indication, 2019-2032 (USD Million)
TABLE Middle East and Africa Nanomedicines Market, by Molecule Type, 2019-2032 (USD Million)

Nanomedicines Market, By Modality, By Application, By Indication, By Molecule Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Nanomedicines Market- Segmentation Analysis:

Nanomedicines Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINES MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOMEDICINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOMEDICINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOMEDICINES MARKET, BY MOLECULE TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL NANOMEDICINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.Nanomedicines Market Overview

2.Executive Summary

3.Nanomedicines Key Market Trends

4.Nanomedicines Industry Study

5.Nanomedicines Market: COVID-19 Impact Analysis

6.Nanomedicines Market Landscape

7.Nanomedicines Market - By Modality

8.Nanomedicines Market - By Application

9.Nanomedicines Market - By Indication

10.Nanomedicines Market - By Molecule Type

11.Nanomedicines Market- By Geography

12.Key Vendor Analysis- Nanomedicines Industry

13.360 Degree Analyst View

14.Appendix

List of Tables